nach oben

Erschienen in:

01.02.2010 | Original Communication

Acute basal ganglia infarcts in poststroke fatigue: an MRI study

verfasst von: Wai Kwong Tang, Yang Kun Chen, Vincent Mok, Winnie C. W. Chu, Gabor S. Ungvari, Anil T. Ahuja, Ka Sing Wong

Erschienen in: Journal of Neurology | Ausgabe 2/2010

Einloggen, um Zugang zu erhalten

Abstract

Lesions located in the basal ganglia (BG) are thought to be involved in the fatigue observed in neurological disorders. However, the significance of the location of infarcts in poststroke fatigue (PSF) is unknown. This study examined the association between BG infarcts and PSF. A total of 334 Chinese patients with acute ischemic stroke consecutively admitted to the acute stroke unit of a university-affiliated regional hospital in Hong Kong participated in the study. At admission, a host of demographic and clinical characteristics was collected and the number and location of acute infarcts were evaluated with MRI. All participants were assessed for PSF with the fatigue severity scale (FSS) 3 months after their index stroke. PSF was defined as a mean FSS score of 4.0 or more. Depressive symptoms were measured by the geriatric depression scale (GDS). Seventy-eight (23.4%) patients had PSF. In the univariate analysis, the PSF group included more females, had higher GDS scores, and a higher number of acute infarcts, and the PSF patients were more likely to have acute infarcts at the BG. Acute BG infarct remained an independent predictor of PSF in the multivariate analysis. In conclusion, these results suggest that BG infarcts may play a role in the development of PSF.

Abudi S, Bar-Tal Y, Ziv L, Fish M (1997) Parkinson’s disease symptoms––patients’ perception. J Adv Nurs 25:54–59CrossRefPubMed

Annoni JM, Staub F, Bogousslavsky J, Brioschi A (2008) Frequency, characterisation and therapies of fatigue after stroke. Neurol Sci 29(Suppl 2):S244–S246CrossRefPubMed

Astrom M, Adolfsson R, Asplund K (1993) Major depression in stroke patients: a 3-year longitudinal study. Stroke 24:976–982PubMed

Brott T, Adams HP Jr, Olinger CP (1989) Measurement of acute cerebral infarctions: a clinical examination scale. Stroke 20:864–870PubMed

Bruno RL, Cohen JM, Galski T, Frick NM (1994) The neuroanatomy of post-polio fatigue. Arch Phys Med Rehab 75:498–504

Capuron L, Miller AH (2004) Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 56:819–824CrossRefPubMed

Capuron L, Pagnoni G, Demetrashvili MF, Lawson DH, Fornwalt FB, Woolwine B, Berns GS, Nemeroff CB, Miller AH (2007) Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology 32:2384–2392CrossRefPubMed

Carlsson GE, Moller A, Blomstrand C (2000) Consequences of mild stroke in persons <75 years––a 1-year follow-up. Cerebrovasc Dis 16:383–388CrossRef

Chaudhuri A, Behan PO (2000) Fatigue and basal ganglia. J Neurol Sci 179(Suppl 1–2):S34–S42CrossRef

10.

Chaudhuri A, Condon BR, Gow JW, Brennan D, Hadley DM (2003) Proton magnetic resonance spectroscopy of basal ganglia in chronic fatigue syndrome. Neuroreport 14:225–228CrossRefPubMed

11.

Chaudhuri A, Behan PO (2004) Fatigue in neurological disorders. Lancet 363:978–988CrossRefPubMed

12.

Chen SX, Yu FM (2008) Syndrome differentiation and treatment of post-stroke fatigue. J Pract Tradit Chin Int Med 22:17–19

13.

Chiu HFK, Lee HCB, Chung D (1994) Reliability and validity of the Cantonese version of the mini-mental state examination: a preliminary study. J Hong Kong Coll Psychiatrists 4:25–28

14.

Choi-Kwon S, Han SW, Kwon SU, Kim JS (2005) Poststroke fatigue: characteristics and related factors. Cerebrovasc Dis 19:84–90CrossRefPubMed

15.

Choi-Kwon S, Choi J, Kwon SU, Kang DW, Kim JS (2007) Fluoxetine is not effective in the treatment of post-stroke fatigue: a double-blind, placebo-controlled study. Cerebrovasc Dis 23:103–108CrossRefPubMed

16.

Colombo B, Martinelli Boneschi F, Rossi P, Rovaris M, Maderna L, Filippi M, Comi G (2000) MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue. J Neurol 247:506–509CrossRefPubMed

17.

De Groot MH, Phillips SJ, Eskes GA (2003) Fatigue associated with stroke and other neurologic conditions: Implications for stroke rehabilitation. Arch Phys Med Rehabil 84:1714–1720CrossRefPubMed

18.

DeLuca J, Genova HM, Hillary FG, Wylie G (2008) Neural correlates of cognitive fatigue in multiple sclerosis using functional MRI. J Neurol Sci 270:28–39CrossRefPubMed

19.

Friedman J, Friedman H (1993) Fatigue in Parkinson’s disease. Neurology 43:2016–2019PubMed

20.

Glader EL, Stegmayr B, Asplund K (2002) Poststroke fatigue: a 2-year follow-up study of stroke patients in Sweden. Stroke 33:1327–1333CrossRefPubMed

21.

Ingles JL, Eskes GA, Phillips SJ (1999) Fatigue after stroke. Arch Phys Med Rehabil 80:173–178CrossRefPubMed

22.

Kam IWK (2000) Development of the bilingual (Chinese/English) SCID-I (Structured Clinical Interview for DSM-IV Axis I disorder): a study of its reliability and validity in an in-patient population. Dissertation for Part III Examination of Fellowship. Hong Kong College of Psychiatrists, Hong Kong

23.

Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123PubMed

24.

Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9:179–186PubMed

25.

Leegaard OF (1983) Diffuse cerebral symptoms in convalescents from cerebral infarction and myocardial infarction. Acta Neurol Scand 67:348–355PubMedCrossRef

26.

Levy R, Czernecki V (2006) Apathy and the basal ganglia. J Neurol 253(Suppl 7):S54–S61

27.

Lim PP, Ng LL, Chiam PC, Ong PS, Ngui FT, Sahadevan S (2000) Validation and comparison of three brief depression scales in an elderly Chinese population. Int J Geriatr Psychiatry 15:824–830CrossRefPubMed

28.

Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md State Med J 14:61–65PubMed

29.

Mills JA, Gonzalez RG, Jaffe R (2008) Case records of the Massachusetts General Hospital. Case 25, 2008. A 43-year-old man with fatigue and lesions in the pituitary and cerebellum. N Engl J Med 359:736–747CrossRefPubMed

30.

Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM (2005) Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovasc Dis 20:245–250CrossRefPubMed

31.

Rammohan KW, Rosenberg JH, Lynn DJ, Blumenfeld AM, Pollak CP, Nagaraja HN (2002) Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry 72:179–183CrossRefPubMed

32.

Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W, Plohmann A, Dellas S, Maguire RP, Missimer J, Radu EW, Steck A, Leenders KL (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a F-fluorodeoxyglucose positron functionally segregated circuits linking basal ganglia and cortex. An emission tomographic study. Neurology 48:1566–1571PubMed

33.

Sandberg O, Franklin KA, Bucht G, Gustafson Y (2001) Sleep apnea, delirium, depressed mood, cognition, and ADL ability after stroke. J Am Geriatr Soc 49:391–397CrossRefPubMed

34.

Schepers VP, Visser-Meily AM, Ketelaar M, Lindeman E (2006) Poststroke fatigue: course and its relation to personal and stroke-related factors. Arch Phys Med Rehabil 87:184–188CrossRefPubMed

35.

Schmidt-Wilcke T, Luerding R, Weigand T, Jurgens T, Schuierer G, Leinisch E, Bogdahn U (2007) Striatal grey matter increase in patients suffering from fibromyalgia––a voxel-based morphometry study. Pain 132(Suppl 1):S106–S109

36.

Schwartz JE, Jandorf L, Krupp LB (1993) The measurement of fatigue: a new instrument. J Psychosom Res 37:753–762CrossRefPubMed

37.

Staub F, Bogousslavsky J (2001) Fatigue after stroke: a major but neglected issue. Cerebrovasc Dis 12:75–81CrossRefPubMed

38.

van de Port IG, Kwakkel G, Schepers VP, Heinemans CT, Lindeman E (2007) Is fatigue an independent factor associated with activities of daily living, instrumental activities of daily living and health-related quality of life in chronic stroke? Cerebrovasc Dis 23:40–45CrossRefPubMed

39.

van der Werf SP, van den Broek HL, Anten HW, Bleijenberg G (2001) Experience of severe fatigue long after stroke and its relation to depressive symptoms and disease characteristics. Eur Neurol 45:28–33CrossRefPubMed

40.

Van Zandvoort MJ, Kappelle LJ, Algra A, De Haan EH (1998) Decreased capacity for mental effort after single supratentorial lacunar infarct may affect performance in everyday life. J Neurol Neurosurg Psychiatry 65:697–702CrossRefPubMed

41.

Vercoulen JH, Hommes OR, Swanink CM, Jongen PJ, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G (1996) The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 53:642–649PubMed

42.

Ziv I, Avraham M, Michaelov Y, Djaldetti R, Dressler R, Zoldan J, Melamed E (1998) Enhanced fatigue during motor performance in patients with Parkinson’s disease. Neurology 51:1583–1586PubMed

Titel: Acute basal ganglia infarcts in poststroke fatigue: an MRI study
verfasst von: Wai Kwong Tang
Yang Kun Chen
Vincent Mok
Winnie C. W. Chu
Gabor S. Ungvari
Anil T. Ahuja
Ka Sing Wong
Publikationsdatum: 01.02.2010
Verlag: D. Steinkopff-Verlag
Erschienen in: Journal of Neurology / Ausgabe 2/2010
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-009-5284-2

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2010

Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis

Mother–child blood group incompatibility and the risk of multiple sclerosis

Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study

Neuroimaging supports central pathology in familial dysautonomia

Alaska, multiple sclerosis, and the vitamin D hypothesis